Patent US5097834A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5097834A Expired / Lapsed US ⏱️ 0.0 years remaining

Process for determining parameters of interest in living organisms

Assignee: SKRABAL FALCO
•
Filing: 1989-08-02
•
Granted: 1992-03-24
•
Expires: 2009-08-02
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract In order to determine at least one parameter of interest in a living organism, a perfusion fluid is directly introduced in the tissues. After its partial balancing by the tissue parameter of interest, the perfusion fluid is collected and analyzed for the parameter of interest, as well as for endogenous or exogenous marker properties indicative of the degree of interaction between the perfusion fluid and the tissue, in such a way that the parameter of interest can be determined with the help of such characteristic properties. Contrary to usual processes, used exclusively inside blood vessels or other body cavities filled with liquid, this process creates in the tissues, i.e. in the closed cellular structure, a previously inexistent cavity, in which the perfusion fluid introduced in the tissue interacts directly with the organic tissue, with no intervening membranes. The transfer of the measurement site into the tissue completely eliminates the risk of the thromboses and embolies, besides strongly reducing the risk of infection.

Inventors

  • 👤 Falko Skrabal

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 16:52
CPC Classifications
A; A61; A61M; A61M5/00; A61M5/14; A61M5/168; A61M5/172; A61M5/1723; A61B; A61B10/00; A61B10/0045; A61B5/00; A61B5/145; A61B5/14525; A61B5/14532; A61B5/14542; A61B5/1468; A61B5/1486; A61B5/14865; A61B5/15; A61B5/150007; A61B5/150015; A61B5/15003; A61B5/150206; A61B5/150244; A61B5/150251; A61B5/150374; A61B5/150381; A61B5/150389; A61B5/150396; A61B5/150503; A61B5/150511; A61B5/153; A61B5/155; A61B5/157; A61B5/48; A61B5/4836; A61B5/4839; A61M1/00; A61M1/71; A61M1/77; A61M1/84; A61M1/85; A61B10/007; A61M2230/00; A61M2230/20; A61M2230/201; A61M2230/65; Y; Y10; Y10S; Y10S128/00; Y10S128/13

Claims Analysis

Total Claims: 17
Claim 1
Independent Claim 125 words
A method for determining the actual concentration of at least one substance to be analyzed in a living organism, comprising the steps of: introducing a perfusion fluid directly into the tissue of said living organism; collecting said perfusion fluid after partial equilibration with said substance to be analyzed; testing said perfusion fluid for said substance to be analyzed to obtain a provisional concentration value of said substance; additionally testing said perfusion fluid for at least one endogenous marker variable with a known tissue value to obtain a test value; calculating the degree of partial equilibration from said tissue value and said test value; and calculating the actual concentration of said substance to be analyzed from said degree of partial equilibration and said provisional concentration value.
Claim 2
Independent Claim 125 words
A method for determining the actual concentration of at least one substance to be analyzed in a living organism, comprising the steps of: introducing a perfusion fluid directly into the tissue of said living organism; collecting said perfusion fluid after partial equilibration with said substance to be analyzed; testing said perfusion fluid for said substance to be analyzed to obtain a provisional concentration value of said substance; additionally testing said perfusion fluid for at least one endogenous marker variable with a known tissue value to obtain a test value; calculating the degree of partial equilibration from said tissue value and said test value; and calculating the actual concentration of said substance to be analyzed from said degree of partial equilibration and said provisional concentration value.
Claim 3
Dependent Claim 33 words
A method according to claim 1 wherein at least one parameter from the group of ionic concentration, conductivity, impedance, osmolarity and density is analyzed as said endogenous marker variable of said perfusion fluid.
Claim 4
Dependent Claim 34 words
A method according to claim 1, wherein an analyzing unit for analyzing said substance to be analyzed and said marker variables is calibrated at specific intervals of time by means of a calibrating medium.
Claim 5
Dependent Claim 23 words
A method according to claim 1, wherein a drug is applied automatically, in accordance with the concentration of said substance to be analyzed.
Claim 6
Dependent Claim 40 words
A method according to claim 1, wherein said substance to be analyzed is glucose, the concentration of said substance to be analyzed being determined along with the endogenous sodium or chloride concentration as said marker variable of said perfusion fluid.
Claim 7
Dependent Claim 36 words
A method according to claim 1, wherein said substance to be analyzed is glucose, the concentration of said substance to be analyzed being determined along with the conductivity as said marker variable of said perfusion fluid.
Claim 8
Dependent Claim 21 words
A method according to claim 1, wherein a low-glucose, low-ion solution of approximately isotonic character is used as said perfusion fluid.
Claim 9
Dependent Claim 24 words
A method according to claim 1, wherein a substrate preventing a reaction of said substance to be analyzed is added to said perfusion fluid.
Claim 10
Dependent Claim 27 words
A method according to claim 8, wherein said substance to be analyzed is glucose and wherein said substrate is 3-phosphoglycerate, which is added to said perfusion fluid.
Claim 11
Dependent Claim 37 words
A method according to claim 1, wherein the diffusion constants of one or more of said marker variables and of said substance to be analyzed are entered for calculating the concentration of said substance to be analyzed.
Claim 12
Dependent Claim 22 words
A method according to claim 1, wherein a gaseous substance is used for separation of said perfusion fluid and a calibrating medium.
Claim 13
Dependent Claim 38 words
A method according to claim 1, wherein said substance to be analyzed and said marker variable are measured by at least two independent analyzing units, and wherein alarm signals are given if said measured values do not match.
Claim 14
Independent Claim 131 words
A method for determining the actual concentration of at least one substance to be analyzed in a living organism, comprising the steps of: introducing a perfusion fluid directly into the tissue of said living organism, said perfusion fluid comprising an exogenous marker substance with known actual concentration; collecting said perfusion fluid after partial equilibration with said substance to be analyzed; testing said perfusion fluid for said substance to be analyzed to obtain a provisional concentration value of said substance; additionally testing said perfusion fluid for said exogenous marker substance to obtain a test value; calculating the degree of partial equilibration from said actual concentration value and said test value; and calculating the actual concentration of said substance to be analyzed from said degree of partial equilibration and said provisional concentration value.
Claim 15
Independent Claim 131 words
A method for determining the actual concentration of at least one substance to be analyzed in a living organism, comprising the steps of: introducing a perfusion fluid directly into the tissue of said living organism, said perfusion fluid comprising an exogenous marker substance with known actual concentration; collecting said perfusion fluid after partial equilibration with said substance to be analyzed; testing said perfusion fluid for said substance to be analyzed to obtain a provisional concentration value of said substance; additionally testing said perfusion fluid for said exogenous marker substance to obtain a test value; calculating the degree of partial equilibration from said actual concentration value and said test value; and calculating the actual concentration of said substance to be analyzed from said degree of partial equilibration and said provisional concentration value.
Claim 16
Dependent Claim 33 words
A method according to claim 13, wherein at least one additional substance to be detected by chemical or physical methods is added to said perfusion fluid for measurement of said exogenous marker substance.
Claim 17
Dependent Claim 40 words
A method according to claim 13, wherein said substance to be analyzed is glucose, the concentration of said substance to be analyzed being determined along with the concentration of a dye added to said perfusion fluid as said marker substance.

References Cited (Backward Citations)

US4253456A Cited
US4221567A Cited
WO1981001794A1 Cited
US4516580A Cited
US4633878A Cited
US4761371A Cited
US4632119A Cited
US4774955A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1995-03-24 1995-09-23 1996-03-24 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1999-03-24 1999-09-23 2000-03-24 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2003-03-24 2003-09-23 2004-03-24 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag